Behind the headlines: 10 million deaths from Antimicrobial resistance by 2050 (or not?)
One of the greatest health threats of our time, one that grows by the year, is antimicrobial resistance. Bacteria and other microbes develop mutations that protect them against antibiotics and other antimicrobial drugs, meaning that infections, including deadly ones, that we can now treat will become more difficult — even possible — to treat. The 700,000 or more deaths that antimicrobial resistance now causes every year could grow to 10 million by 2050.
It could cause 10 million deaths per year by 2050. But just how likely is this?
Read an article or book discussing antimicrobial resistance, and you would think that without more action to combat resistance (such as by developing new antibiotics and other antimicrobials) and slow its spread (such as through more prudent use of existing antibiotics), we are on track to that truly frightening future. It would be a future where more people die of antimicrobial resistance than cancer, and today’s routine surgeries become dangerous – even too dangerous to undertake – because of the risk of deadly infections.
Boosting innovation in AMR?
15 OCT 2020: online Kick Off event AMR Innovation Mission UK 2021
The AMR Innovation Mission UK 2020/2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.